IP Library Granted Patent US 10,384,061
Granted Patent B2
US 10,384,061 · App. 14/992,921 · Granted Aug 20, 2019

Methods and devices for treating primary headache

Inventors: Bruce J. Simon (Mountain Lakes, NJ); Joseph P. Errico (Warren, NJ); John T. Raffle (Austin, TX)
Assignee: Electrocore, Inc.
A61N1/36021A61N1/0456A61N1/36075A61N1/40A61N2/006A61N2/008A61N2/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,384,061
App. No.
14/992,921
Granted
Aug 20, 2019
Kind
B2
Abstract

Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.

Claims (31)

1. A method for treating a medical disorder in a patient, the method comprising:

positioning a device adjacent to a skin surface of a neck of the patient;

generating one or more electrical impulses with the device; and

transmitting, via the device, the one or more electrical impulses to a vagus nerve of the patient, wherein the one or more electrical impulses is above a threshold for generating an action potential within a fiber of the vagus nerve responsible for activating neural pathways to cause a release of a sufficient level of an inhibitory neurotransmitter within a brain of the patient and is sufficient to reduce a level of glutamate in the brain of the patient to at least partially relieve a symptom associated with the medical disorder.

2. The method of claim 1 , wherein the inhibitory neurotransmitter comprises GABA.

3. The method of claim 1 , wherein the inhibitory neurotransmitter comprises serotonin.

4. The method of claim 1 , wherein the inhibitory neurotransmitter comprises norepinephrine.

5. The method of claim 1 , wherein the one or more electrical impulses comprises bursts of pulses.

6. The method of claim 5 , wherein the bursts of pulses are generated from a signal that is not modulated by another signal.

7. The method of claim 5 , wherein each burst comprises a frequency from about 1 Hz to about 100 Hz.

8. The method of claim 5 , wherein each burst comprises a frequency from about 10 Hz to about 35 Hz.

9. The method of claim 5 , wherein each pulse comprises a duration from about 50 microseconds to about 1000 microseconds.

10. The method of claim 5 , wherein each pulse comprises a duration from about 200 microseconds to about 400 microseconds.

11. The method of claim 1 , wherein the medical disorder comprises a primary headache.

12. A device for treating a medical disorder in a patient, the device comprising:

a housing comprising:

an electrode,

an electrically permeable contact surface configured for contacting an outer skin surface of a neck of the patient, wherein the electrically permeable contact surface is coupled to the electrode, and

a source of energy (a) configured to generate an electric field sufficient to reduce a level of glutamate within a brain of the patient to at least partially relieve a symptom of the medical disorder, (b) coupled to the electrode, and (c) positioned within the housing,

wherein the electric field is sufficient to transmit an electric current non-invasively through the electrically permeable contact surface and the outer skin surface of the patient to a vague nerve of the patient, wherein the electric current is above a threshold for generating an action potential within a fiber of the vagus nerve responsible for activating a neural pathway causing a release of an inhibitory neurotransmitter.

13. The device of claim 12 , wherein the inhibitory neurotransmitter comprises GABA.

14. The device of claim 12 , wherein the inhibitory neurotransmitter comprises serotonin.

15. The device of claim 12 , wherein the inhibitory neurotransmitter comprises norepinephrine.

16. The device of claim 12 , further comprising one or more electrodes and a signal generator coupled to each other within the housing.

17. The device of claim 12 , wherein the electric current comprises bursts of pulses.

18. The device of claim 17 , wherein the bursts of pulses are generated from a signal that is not modulated by another signal.

19. The device of claim 17 , wherein each burst comprises a frequency from about 1 Hz to about 100 Hz.

20. The device of claim 17 , wherein each burst comprises a frequency from about 10 Hz to about 35 Hz.

21. The device of claim 17 , wherein each pulse comprises a duration from about 50 microseconds to about 1000 microseconds.

22. The device of claim 17 , wherein each pulse comprises a duration from about 200 microseconds to about 400 microseconds.

23. The device of claim 12 , wherein the medical disorder comprises a primary headache.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: SIMON, BRUCE J.; ERRICO, JOSEPH P.; RAFFLE, JOHN T.
To: ELECTROCORE, LLC
Reel/Frame 037456/0721 →
Continuity (20)
Continuation 14229894 · Mar 29, 2014
Division 13109250 · May 17, 2011
Continuation In Part 13075746 · Mar 30, 2011
Continuation In Part 13024727 · Feb 10, 2011
Continuation In Part 13005005 · Jan 12, 2011
Continuation In Part 12964050 · Dec 9, 2010
Continuation In Part 12859568 · Aug 19, 2010
Continuation In Part 12612177 · Nov 1, 2009
Continuation In Part 11592095 · Nov 2, 2006
Continuation In Part 12408131 · Mar 20, 2009
Continuation In Part 11591340 · Nov 1, 2006
Provisional Application 61471405 · Apr 4, 2011
Provisional Application 61451259 · Mar 10, 2011
Provisional Application 61415469 · Nov 19, 2010
Provisional Application 60814312 · Jun 16, 2006
Provisional Application 60772361 · Feb 10, 2006
Provisional Application 60814313 · Jun 16, 2006
Provisional Application 60786564 · Mar 28, 2006
Provisional Application 60772361 · Feb 10, 2006
Related Publication 20160121116A1 · May 5, 2016